In 1978, building on this discovery, Zamecnik and Stephenson 32 used specific oligodeoxynucleotide chains that target the 35S RNA of the Rous sarcoma virus to inhibit virus replication, marking a prototype for the application of antisense oligonucleotide (ASO) drugs in disease treatment
For the full show notes, please visit hubermanlab.com
Clinical endpoints included the Ocular Surface Disease Index (OSDI), FACES scale, tear film break-up time (TFBUT), Schirmer test, and NEI fluorescein staining
Im losing weight steadily and feeling great
Estrogen activation of G-Protein-coupled Estrogen Receptor 1 regulates Phosphoinositide 3-Kinase and mTOR signaling to promote liver growth in zebrafish and proliferation of human hepatocytes
Long-term safety data remains limited compared to semaglutide